Andrographolide induces apoptosis of C6 glioma cells via the ERK-p53-caspase 7-PARP pathway

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Yang, Shih Hung ^a   Wang, Seu Mei ^b   Syu, Jhih Pu ^b   Chen, Ying ^c   Wang, Sheng De ^b   Peng, Yu Sen ^d   Kuo, Meng Fai ^a   Kung, Hsiu Ni ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGRAPHOLIDE; CASPASE 7; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; CASP7 PROTEIN, MOUSE; DITERPENE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CANCER GROWTH; CANCER REGRESSION; CONTROLLED STUDY; DRUG DETERMINATION; GLIOMA CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; DRUG EFFECTS; GENETICS; GLIOMA; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DITERPENES; GLIOMA; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84929938499     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/312847     Document Type: Article

References (69)

1. CBTRUS, Statistical Report: Primary Brain Tumors in the United States, 2000-2004, Central Brain Tumor Registry of the United States, Hinsdale, Ill, USA, 2008.
2. G. Karpel-Massler, U. Schmidt, A. Unterberg, and M. Halatsch, "Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?" Molecular Cancer Research, vol. 7, no. 7, pp. 1000-1012, 2009.
3. A. Narayana, P. Kelly, J. Golfinos et al., "Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival, " Journal of Neurosurgery, vol. 110, no. 1, pp. 173-180, 2009.
4. K. L. Chandler, M. D. Prados, M. Malec, and C. B. Wilson, "Long-termsurvival in patients with glioblastomamultiforme, " Neurosurgery, vol. 32, no. 5, pp. 716-720, 1993.
5. M. Salcman, "Survival in glioblastoma: Historical perspective, " Neurosurgery, vol. 7, no. 5, pp. 435-439, 1980.
6. S. Suebsasana, P. Pongnaratorn, J. Sattayasai, T. Arkaravichien, S. Tiamkao, and C. Aromdee, "Analgesic, antipyretic, antiinflammatory and toxic effects of andrographolide derivatives in experimental animals, " Archives of Pharmacal Research, vol. 32, no. 9, pp. 1191-1200, 2009.
7. S. R. Naik and A. Hule, "Evaluation of immunomodulatory activity of an extract of andrographolides from Andographis paniculata, " Planta Medica, vol. 75, no. 8, pp. 785-791, 2009.
8. P. K. S. Visen, B. Shukia, G. K. Patnaik, and B. N. Dhawan, "Andrographolide protects rat hepatocytes against paracetamol-induced damage, " Journal of Ethnopharmacology, vol. 40, no. 2, pp. 131-136, 1993.
9. C. Wiart, K. Kumar, M. Y. Yusof, H. Hamimah, Z. M. Fauzi, and M. Sulaiman, "Antiviral properties of ent-labdene diterpenes of Andrographis paniculata Nees, inhibitors of herpes simplex virus type 1, " Phytotherapy Research, vol. 19, no. 12, pp. 1069-1070, 2005.
10. F. Zhao, E. Q. He, L. Wang, and K. Liu, "Anti-tumor activities of andrographolide, a diterpene fromAndrographis paniculata, by inducing apoptosis and inhibiting VEGF level, " Journal of Asian Natural Products Research, vol. 10, no. 5-6, pp. 467-473, 2008.
11. J. Y. Chun, R. Tummala, N. Nadiminty et al., "Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppresses prostate cancer cell growth, " Genes and Cancer, vol. 1, no. 8, pp. 868-876, 2010.
12. C. Jiang, J. Li, F. Liu, T. Wu, M. Yu, and H. Xu, "Andrographolide inhibits the adhesion of gastric cancer cells to endothelial cells by blocking E-selectin expression, " Anticancer Research, vol. 27, no. 4, pp. 2439-2447, 2007.
13. S. Rajagopal, R. A. Kumar, D. S. Deevi, C. Satyanarayana, and R. Rajagopalan, "Andrographolide, a potential cancer therapeutic agent isolated fromAndrographis paniculata, " Journal of Experimental Therapeutics and Oncology, vol. 3, no. 3, pp. 147-158, 2003.
14. S. Sukumari-Ramesh, J. N. Bentley, M. D. Laird, N. Singh, J. R. Vender, and K. M. Dhandapani, "Dietary phytochemicals induce p53-and caspase-independent cell death in human neuroblastoma cells, " International Journal of Developmental Neuroscience, vol. 29, no. 7, pp. 701-710, 2011.
15. H. R. Tsai, L. M. Yang, W. J. Tsai, and W. F. Chiou, "Andrographolide acts through inhibition of ERK1/2 andAkt phosphorylation to suppress chemotactic migration, " European Journal of Pharmacology, vol. 498, no. 1-3, pp. 45-52, 2004.
16. M. D. Shi, H. H. Lin, Y. C. Lee, J. K. Chao, R. A. Lin, and J. H. Chen, "Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide, " Chemico-Biological Interactions, vol. 174, no. 3, pp. 201-210, 2008.
17. J. Zhou, G. Lu, C. Ong, C. Ong, and H. Shen, "Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation, " Molecular Cancer Therapeutics, vol. 7, no. 7, pp. 2170-2180, 2008.
18. Y. Tan, K. H. Chiow, D. Huang, and S. H. Wong, "Andrographolide regulates epidermal growth factor receptor and transferrin receptor trafficking in epidermoid carcinoma (A-431) cells, " British Journal of Pharmacology, vol. 159, no. 7, pp. 1497-1510, 2010.
19. Y. C. Lee, H. H. Lin, C. H. Hsu, C. J. Wang, T. A. Chiang, and J. H. Chen, "Inhibitory effects of andrographolide on migration and invasion in human non-small cell lung cancer A549 cells via down-regulation of PI3K/Akt signaling pathway, " European Journal of Pharmacology, vol. 632, no. 1-3, pp. 23-32, 2010.
20. M. Shi, H. Lin, T. Chiang et al., "Andrographolide could inhibit human colorectal carcinoma Lovo cells migration and invasion via down-regulation ofMMP-7 expression, " Chemico-Biological Interactions, vol. 180, no. 3, pp. 344-352, 2009.
21. H. H. Lin, C. W. Tsai, F. P. Chou et al., "Andrographolide downregulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells, " Toxicology and Applied Pharmacology, vol. 250, no. 3, pp. 336-345, 2011.
22. K. Sheeja, C. Guruvayoorappan, and G. Kuttan, "Antiangiogenic activity of Andrographis paniculata extract and andrographolide, " International Immunopharmacology, vol. 7, no. 2, pp. 211-221, 2007.
23. H. Cheung, S. Cheung, J. Li et al., "Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells, " Planta Medica, vol. 71, no. 12, pp. 1106-1111, 2005.
24. P. Pratheeshkumar, K. Sheeja, and G. Kuttan, "Andrographolide induces apoptosis in B16F-10 melanoma cells by inhibiting NF-κB-mediated bcl-2 activation and modulating p53-induced caspase-3 gene expression, " Immunopharmacology and Immunotoxicology, vol. 34, no. 1, pp. 143-151, 2012.
25. Y. Li, P. Zhang, F. Qiu et al., "Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells, " Life Sciences, vol. 90, no. 25-26, pp. 962-967, 2012.
26. L. Ji, T. Liu, J. Liu, Y. Chen, and Z. Wang, "Andrographolide inhibits human hepatoma-derived Hep3B cell growth through the activation of c-Jun N-terminal kinase, " Planta Medica, vol. 73, no. 13, pp. 1397-1401, 2007.
27. B. Grobben, P. P. De Deyn, and H. Slegers, "Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion, " Cell and Tissue Research, vol. 310, no. 3, pp. 257-270, 2002.
28. C. Liao, S. Wang, Y. Chen, H. Wang, and J. Wu, "Lipopolysaccharide-induced inhibition of connexin43 gap junction communication in astrocytes ismediated by downregulation of caveolin-3, " The International Journal of Biochemistry and Cell Biology, vol. 42, no. 5, pp. 762-770, 2010.
29. L. Fang, V. C. Lee, E. Cha, H. Zhang, and S. T. Hwang, "CCR7 regulates B16 murine melanoma cell tumorigenesis in skin, " Journal of Leukocyte Biology, vol. 84, no. 4, pp. 965-972, 2008.
30. T. Hoshida, N. Isaka, J. Hagendoorn et al., "Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications, " Cancer Research, vol. 66, no. 16, pp. 8065-8075, 2006.
31. G. B. Thurman, D. L. Page, B. D. Wamil, L. E. Wilkinson, M. Kasami, and C. G. Hellerqvist, "Acute inflammatory changes in subcutaneous microtumors in the ears of mice induced by intravenous CM101 (GBS toxin), " Journal of Cancer Research and Clinical Oncology, vol. 122, no. 9, pp. 549-553, 1996.
32. X. Wu, R. E. Sells, and S. T. Hwang, "Upregulation of inflammatory cytokines and oncogenic signal pathways preceding tumor formation in a murine model of T-cell lymphoma in skin, " Journal of Investigative Dermatology, vol. 131, no. 8, pp. 1727-1734, 2011.
33. T. Fernandes-Alnemri, A. Takahashi, R. Armstrong et al., "Mch3, a novel human apoptotic cysteine protease highly related to CPP32, " Cancer Research, vol. 55, no. 24, pp. 6045-6052, 1995.
34. J. A. Lippke, Y. Gu, C. Sarnecki, P. R. Caron, and M. S.-. Su, "Identification and characterization of CPP32/Mch2 homolog l, a novel cysteine protease similar to CPP32, " Journal of Biological Chemistry, vol. 271, no. 4, pp. 1825-1828, 1996.
35. M. Germain, E. B. Affar, D. D'Amours, V. M. Dixit, G. S. Salvesen, and G. G. Poirier, "Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis: evidence for involvement of caspase-7, " The Journal of Biological Chemistry, vol. 274, no. 40, pp. 28379-28384, 1999.
36. G. M. Cohen, "Caspases: The executioners of apoptosis, " Biochemical Journal, vol. 326, part 1, pp. 1-16, 1997.
37. G. Nunez, M. A. Benedict, Y. Hu, and N. Inohara, "Caspases: the proteases of the apoptotic pathway, " Oncogene, vol. 17, no. 25, pp. 3237-3245, 1998.
38. G. Fusaro, P. Dasgupta, S. Rastogi, B. Joshi, and S. Chellappan, "Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling, " Journal of Biological Chemistry, vol. 278, no. 48, pp. 47853-47861, 2003.
39. S. Kenig, R. Frangez, A. Pucer, and T. Lah, "Inhibition of cathepsin L lowers the apoptotic threshold of glioblastoma cells by up-regulating p53 and transcription of caspases 3 and 7, " Apoptosis, vol. 16, no. 7, pp. 671-682, 2011.
40. C. Bellodi, N. Kopmar, and D. Ruggero, "Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita, " The EMBO Journal, vol. 29, no. 11, pp. 1865-1876, 2010.
41. M. E. Wall, M. C. Wani, C. E. Cook, K. H. Palmer, A. T. McPhail, and G. A. Sim, "Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata, " Journal of the American Chemical Society, vol. 88, no. 16, pp. 3888-3890, 1966.
42. M. Sawada, S. Nakashima, Y. Banno et al., "Ordering of ceramide formation, caspase activation, and Bax/Bcl-2 expression during etoposide-induced apoptosis in C6 glioma cells, " Cell Death and Differentiation, vol. 7, no. 9, pp. 761-772, 2000.
43. T. C. Kuo, J. S. Yang, M. W. Lin et al., "Emodin has cytotoxic and protective effects in rat C6 glioma cells: roles of Mdr1a and nuclear factor κB in cell survival, " Journal of Pharmacology and Experimental Therapeutics, vol. 330, no. 3, pp. 736-744, 2009.
44. Y. Xu, Y. Zhang, X. Liu et al., "The effects of ultrasound and arsenic trioxide on neurogliocytoma cells and secondary activation of macrophages, " Tumori, vol. 95, no. 6, pp. 780-788, 2009.
45. J. Yan, Y. Chen, C. He, Z. Yang, C. Lu, and X. Chen, "Andrographolide induces cell cycle arrest and apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes, " Cell Biology and Toxicology, vol. 28, no. 1, pp. 47-56, 2012.
46. W. Chen, L. Feng, H. Nie, and X. Zheng, "Andrographolide induces autophagic cell death in human liver cancer cells through cyclophilin D-mediated mitochondrial permeability transition pore, " Carcinogenesis, vol. 33, no. 11, pp. 2190-2198, 2012.
47. M. T. W. Cheung, R. Ramalingam, K. K. K. Lau et al., "Cell type-dependent effects of andrographolide on human cancer cell lines, " Life Sciences, vol. 91, no. 15-16, pp. 751-760, 2012.
48. J. Li, H.-Y. Cheung, Z. Zhang, G. K. L. Chan, and W.-F. Fong, "Andrographolide induces cell cycle arrest at G2/M phase and cell death in HepG2 cells via alteration of reactive oxygen species, " European Journal of Pharmacology, vol. 568, no. 1-3, pp. 31-44, 2007.
49. H. P. Chao, C. D. Kuo, J. H. Chiu, and S. L. Fu, "Andrographolide exhibits anti-invasive activity against colon cancer cells via inhibition of MMP2 activity, " Planta Medica, vol. 76, no. 16, pp. 1827-1833, 2010.
50. T. T. T. Nguyen, E. Tran, T. H. Nguyen, P. T. Do, T. H. Huynh, and H. Huynh, "The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells, " Carcinogenesis, vol. 25, no. 5, pp. 647-659, 2004.
51. I. Wortzel and R. Seger, "The ERK cascade: distinct functions within various subcellular organelles, " Genes and Cancer, vol. 2, no. 3, pp. 195-209, 2011.
52. X. Shu, W. Wu, R. D. Mosteller, and D. Broek, "Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases, " Molecular and Cellular Biology, vol. 22, no. 22, pp. 7758-7768, 2002.
53. S. Guise, D. Braguer, G. Carles, A. Delacourte, and C. Briand, "Hyperphosphorylation of tau is mediated by ERK activation during anticancer drug-induced apoptosis in neuroblastoma cells, " Journal of Neuroscience Research, vol. 63, no. 3, pp. 257-267, 2001.
54. J. D. Amaral, J. M. Xavier, C. J. Steer, and C. M. Rodrigues, "The role of p53 in apoptosis., " Discovery Medicine, vol. 9, no. 45, pp. 145-152, 2010.
55. N. D. Lakin and S. P. Jackson, "Regulation of p53 in response to DNA damage, " Oncogene, vol. 18, no. 53, pp. 7644-7655, 1999.
56. E. Han, F. L. Muller, V. I. Perez et al., "The in vivo gene expression signature of oxidative stress, " Physiological Genomics, vol. 34, no. 1, pp. 112-126, 2008.
57. S. W. Gen, "The functional interactions between the p53 and MAPK signaling pathways, " Cancer Biology and Therapy, vol. 3, no. 2, pp. 156-161, 2004.
58. D. L. Persons, E. M. Yazlovitskaya, and J. C. Pelling, "Effect of extracellular signal-regulated kinase on p53 accumulation in response to cisplatin, " The Journal of Biological Chemistry, vol. 275, no. 46, pp. 35778-35785, 2000.
59. Q. She, A. M. Bode, W. Ma, N. Chen, and Z. Dong, "Resveratrolinduced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase, " Cancer Research, vol. 61, no. 4, pp. 1604-1610, 2001.
60. A. Rodriguez-Hernandez, G. Brea-Calvo, D. J. M. Fernandez-Ayala, M. Cordero, P. Navas, and J. A. Sanchez-Alcazar, "Nuclear caspase-3 and capase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis, " Apoptosis, vol. 11, no. 1, pp. 131-139, 2006.
61. C. Schult, M. Dahlhaus, S. Ruck et al., "The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B-and Tlymphoblastic cells, " BMC Cancer, vol. 10, article 560, 2010.
62. D. Boucher, V. Blais, and J. Denault, "Caspase-7 uses an exosite to promote poly(ADP ribose) polymerase 1 proteolysis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 15, pp. 5669-5674, 2012.
63. M. Don, Y. Chang, K. Chen, L. Ho, and Y. Chau, "Induction of CDK inhibitors (p21 WAF1 and p27 Kip1) and BAK in the β-lapachone-induced apoptosis of human prostate cancer cells, " Molecular Pharmacology, vol. 59, no. 4, pp. 784-794, 2001.
64. S. Haupt, M. Berger, Z. Goldberg, and Y. Haupt, "Apoptosis-the p53 network, " Journal of Cell Science, vol. 116, no. 20, pp. 4077-4085, 2003.
65. D. W. Nicholson and N. A. Thornberry, "Apoptosis: life and death decisions, " Science, vol. 299, no. 5604, pp. 214-215, 2003.
66. T. J. Matos, C. B. Duarte, M. Goncalo, and M. C. Lopes, "Role of oxidative stress in ERK and p38 MAPK activation induced by the chemical sensitizer DNFB in a fetal skin dendritic cell line, " Immunology and Cell Biology, vol. 83, no. 6, pp. 607-614, 2005.
67. K. Arai, S. R. Lee, K. van Leyen, H. Kurose, and E. H. Lo, "Involvement of ERK MAP kinase in endoplasmic reticulum stress in SH-SY5Y human neuroblastoma cells, " Journal of Neurochemistry, vol. 89, no. 1, pp. 232-239, 2004.
68. L. Ji, K. Shen, J. Liu, Y. Chen, T. Liu, and Z. Wang, "Intracellular glutathione regulatesAndrographolide-induced cytotoxicity on hepatomaHep3B cells, " Redox Report, vol. 14, no. 4, pp. 176-184, 2009.
69. Y. Y. Zhu, G. Yu, Y. Zhang et al., "A novel andrographolide derivative AL-1 exerts its cytotoxicity on K562 cells through a ROS-dependent mechanism, " Proteomics, vol. 13, no. 1, pp. 169-178, 2013.